Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2024-02-06 00:00:00 ET · period of report 2024-02-02 · accession 0000905148-24-000447 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-06 | 2024-02-02+ | RIGL | Santos David A | EVP, Chief Commercial Off | S - Sale | $1.14 | -14.5K | 349.1K | -4% | -$16.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-02 | S | D | 5,601 | $1.13 | 358,011 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-05 | S | D | 8,918 | $1.14 | 349,093 | D | — | — |